Detecting Early Pancreatic Cancer: Problems and Prospects

Seminars in Oncology

Volumn 34, Issue 4, 2007, Pages 284-294

  Chari, Suresh T ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLIN; BRCA2 PROTEIN; GLUCOSE; TUMOR MARKER;

ARTICLE; CANCER CELL CULTURE; CANCER DIAGNOSIS; CANCER GROWTH; CANCER INVASION; CANCER MORTALITY; CANCER RISK; CANCER SCREENING; CANCER SIZE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CARCINOMA IN SITU; CELL CULTURE; CELL STIMULATION; CLINICAL FEATURE; COLORECTAL CANCER; COMPUTER ASSISTED TOMOGRAPHY; COST EFFECTIVENESS ANALYSIS; DEMOGRAPHY; DIABETES MELLITUS; EARLY CANCER; ECHOGRAPHY; FAMILIAL ATYPICAL MULTIPLE MOLE MELANOMA SYNDROME; GENE MUTATION; GLUCOSE INTOLERANCE; HIGH RISK POPULATION; HORMONE RELEASE; IMAGING; INVASIVE PROCEDURE; NONHUMAN; PANCREAS CANCER; PANCREAS ISLET CELL; PANCREATITIS; PEUTZ JEGHERS SYNDROME; PHENOTYPE; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; SCID MOUSE; SEROLOGY; SUPERNATANT; TIME;

CARCINOMA, PANCREATIC DUCTAL; DIABETES MELLITUS; EARLY DIAGNOSIS; ENDOSONOGRAPHY; HUMANS; PANCREATIC NEOPLASMS; PRECANCEROUS CONDITIONS; RISK FACTORS; TIME FACTORS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 34547452750     PISSN: 00937754     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.seminoncol.2007.05.005     Document Type: Article

References (63)

1. Jemal A., Siegel R., Ward E., et al. Cancer Statistics, 2007. CA Cancer J Clin 57 (2007) 43-66
2. Conlon K.C., Klimstra D.S., and Brennan M.F. Long-term survival after curative resection for pancreatic ductal adenocarcinoma. Clinicopathologic analysis of 5-year survivors. Ann Surg 223 (1996) 273-279
3. Maire F., Sauvanet A., Trivin F., et al. Staging of pancreatic head adenocarcinoma with spiral CT and endoscopic ultrasonography: An indirect evaluation of the usefulness of laparoscopy. Pancreatology 4 (2004) 436-440
4. Karmazanovsky G., Fedorov V., Kubyshkin V., et al. Pancreatic head cancer: Accuracy of CT in determination of resectability. Abdom Imaging 30 (2005) 488-500
5. Roche C.J., Hughes M.L., Garvey C.J., et al. CT and pathologic assessment of prospective nodal staging in patients with ductal adenocarcinoma of the head of the pancreas. AJR Am J Roentgenol 180 (2003) 475-480
6. Sohn T.A., Yeo C.J., Cameron J.L., et al. Resected adenocarcinoma of the pancreas-616 patients: results, outcomes, and prognostic indicators. J Gastrointest Surg 4 (2000) 567-579
7. Neoptolemos J.P., Stocken D.D., Friess H., et al. A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer. N Engl J Med 350 (2004) 1200-1210
8. Tsuchiya R., Noda T., Harada N., et al. Collective review of small carcinomas of the pancreas. Ann Surg 203 (1986) 77-81
9. Furukawa H., Okada S., Saisho H., et al. Clinicopathologic features of small pancreatic adenocarcinoma. A collective study. Cancer 78 (1996) 986-990
10. Shimizu Y., Yasui K., Matsueda K., et al. Small carcinoma of the pancreas is curable: New computed tomography finding, pathological study and postoperative results from a single institute. J Gastroenterol Hepatol 20 (2005) 1591-1594
11. Ishikawa O., Ohigashi H., Imaoka S., et al. Minute carcinoma of the pancreas measuring 1 cm or less in diameter-Collective review of Japanese case reports. Hepatogastroenterology 46 (1999) 8-15
12. Hruban R.H., Goggins M., Parsons J., et al. Progression model for pancreatic cancer. Clin Cancer Res 6 (2000) 2969-2972
13. Adsay N.V., Merati K., Andea A., et al. The dichotomy in the preinvasive neoplasia to invasive carcinoma sequence in the pancreas: Differential expression of MUC1 and MUC2 supports the existence of two separate pathways of carcinogenesis. Mod Pathol 15 (2002) 1087-1095
14. Brentnall T.A., Bronner M.P., Byrd D.R., et al. Early diagnosis and treatment of pancreatic dysplasia in patients with a family history of pancreatic cancer. Ann Intern Med 131 (1999) 247-255
15. Kimura W. How many millimeters do atypical epithelia of the pancreas spread intraductally before beginning to infiltrate?. Hepatogastroenterology 50 (2003) 2218-2224
16. Brat D.J., Lillemoe K.D., Yeo C.J., et al. Progression of pancreatic intraductal neoplasias to infiltrating adenocarcinoma of the pancreas. Am J Surg Pathol 22 (1998) 163-169
17. Brockie E., Anand A., and Albores-Saavedra J. Progression of atypical ductal hyperplasia/carcinoma in situ of the pancreas to invasive adenocarcinoma. Ann Diagn Pathol 2 (1998) 286-292
18. Gangi S., Fletcher J.G., Nathan M.A., et al. Time interval between abnormalities seen on CT and the clinical diagnosis of pancreatic cancer: Retrospective review of CT scans obtained before diagnosis. AJR Am J Roentgenol 182 (2004) 897-903
19. Rulyak S.J., Kimmey M.B., Veenstra D.L., et al. Cost-effectiveness of pancreatic cancer screening in familial pancreatic cancer kindreds. Gastrointest Endosc 57 (2003) 23-29
20. Ghadirian P., Boyle P., Simard A., et al. Reported family aggregation of pancreatic cancer within a population-based case-control study in the Francophone community in Montreal, Canada. Int J Pancreatol 10 (1991) 183-196
21. Arnold M.A., and Goggins M. BRCA2 and predisposition to pancreatic and other cancers. Exp Rev Mol Med 3 (2001) 1-10
22. Goggins M., Schutte M., Lu J., et al. Germline BRCA2 gene mutations in patients with apparently sporadic pancreatic carcinomas. Cancer Res 56 (1996) 5360-5364
23. Ozcelik H., Schmocker B., Di Nicola N., et al. Germline BRCA2 6174delT mutations in Ashkenazi Jewish pancreatic cancer patients. Nat Genet 16 (1997) 17-18
24. Murphy K.M., Brune K.A., Griffin C., et al. Evaluation of candidate genes MAP2K4, MADH4, ACVR1B, and BRCA2 in familial pancreatic cancer: Deleterious BRCA2 mutations in 17%. Cancer Res 62 (2002) 3789-3793
25. Hahn S.A., Greenhalf B., Ellis I., et al. BRCA2 germline mutations in familial pancreatic carcinoma. J Natl Cancer Inst 95 (2003) 214-221
26. Watson P., and Lynch H.T. Extracolonic cancer in hereditary nonpolyposis colorectal cancer. Cancer 71 (1993) 677-685
27. Bergman W., Watson P., de Jong J., et al. Systemic cancer and the FAMMM syndrome. Br J Cancer 61 (1990) 932-936
28. Goldstein A.M., Fraser M.C., Struewing J.P., et al. Increased risk of pancreatic cancer in melanoma-prone kindreds with p16INK4 mutations. N Engl J Med 333 (1995) 970-974
29. Lowenfels A.B., Maisonneuve P., Cavallini G., et al., International Pancreatitis Study Group. Pancreatitis and the risk of pancreatic cancer. N Engl J Med 328 (1993) 1433-1437
30. Lowenfels A.B., Maisonneuve P., Whitcomb D.C., and International Hereditary Pancreatitis Study Group. Risk factors for cancer in hereditary pancreatitis. Med Clin North Am 84 (2000) 565-573
31. Lowenfels A.B., Maisonneuve P., Whitcomb D.C., et al. Cigarette smoking as a risk factor for pancreatic cancer in patients with hereditary pancreatitis. JAMA 286 (2001) 169-170
32. Klein A.P., Brune K.A., Petersen G.M., et al. Prospective risk of pancreatic cancer in familial pancreatic cancer kindreds. Cancer Res 64 (2004) 2634-2638
33. Everhart J., and Wright D. Diabetes mellitus as a risk factor for pancreatic cancer. A meta- analysis. JAMA 273 (1995) 1605-1609
34. Ragozzino M., Jd Melton L., Chu C.P., et al. Subsequent cancer risk in the incidence cohort of Rochester, Minnesota, residents with diabetes mellitus. J Chronic Dis 35 (1982) 13-19
35. Wideroff L., Gridley G., Mellemkjaer L., et al. Cancer incidence in a population-based cohort of patients hospitalized with diabetes mellitus in Denmark. J Natl Cancer Inst 89 (1997) 1360-1365
36. Calle E.E., Murphy T.K., Rodriguez C., et al. Diabetes mellitus and pancreatic cancer mortality in a prospective cohort of United States adults. Cancer Causes Control 9 (1998) 403-410
37. Adami H.O., McLaughlin J., Ekbom A., et al. Cancer risk in patients with diabetes mellitus. Cancer Causes Control 2 (1991) 307-314
38. Chow W.H., Gridley G., Nyren O., et al. Risk of pancreatic cancer following diabetes mellitus: A nationwide cohort study in Sweden. J Natl Cancer Inst 87 (1995) 930-931
39. Noy A., and Bilezikian J.P. Clinical review 63: Diabetes and pancreatic cancer: Clues to the early diagnosis of pancreatic malignancy. J Clin Endocrinol Metab 79 (1994) 1223-1231
40. Gullo L., Pezzilli R., Morselli-Labate A.M., and Italian Pancreatic Cancer Study Group. Diabetes and the risk of pancreatic cancer. N Engl J Med 331 (1994) 81-84
41. Cersosimo E., Pisters P.W., Pesola G., et al. Insulin secretion and action in patients with pancreatic cancer. Cancer 67 (1991) 486-493
42. Permert J., Ihse I., Jorfeldt L., et al. Pancreatic cancer is associated with impaired glucose metabolism. Eur J Surg 159 (1993) 101-107
43. Permert J., Larsson J., Ihse I., et al. Diagnosis of pancreatic cancer. Alteration of glucose metabolism. Int J Pancreatol 9 (1991) 113-117
44. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 20 (1997) 1183-1197
45. Chari S.T., Klee G.G., Miller L.J., et al. Islet amyloid polypeptide is not a satisfactory marker for detecting pancreatic cancer. Gastroenterology 121 (2001) 640-645
46. Permert J., Ihse I., Jorfeldt L., et al. Improved glucose metabolism after subtotal pancreatectomy for pancreatic cancer. Br J Surg 80 (1993) 1047-1050
47. Basso D., Brigato L., Veronesi A., et al. The pancreatic cancer cell line MIA PaCa2 produces one or more factors able to induce hyperglycemia in SCID mice. Anticancer Res 15 (1995) 2585-2588
48. Wang F., Larsson J., Abdiu A., et al. Dissociated secretion of islet amyloid polypeptide and insulin in serum-free culture media conditioned by human pancreatic adenocarcinoma cell lines. Int J Pancreatol 21 (1997) 157-164
49. Ding X., Flatt P.R., Permert J., et al. Pancreatic cancer cells selectively stimulate islet beta cells to secrete amylin. Gastroenterology 114 (1998) 130-138
50. Ahren B., and Andren-Sandberg A. Glucose tolerance and insulin secretion in experimental pancreatic cancer in the Syrian hamster. Res Exp Med 193 (1993) 21-26
51. Moossa A.R., and Levin B. Collaborative studies in the diagnosis of pancreatic cancer. Semin Oncol 6 (1979) 298-308
52. Jain M., Howe G.R., St Louis P., et al. Coffee and alcohol as determinants of risk of pancreas cancer: A case-control study from Toronto. Int J Cancer 47 (1991) 384-389
53. Damiano J., Bordier L., Le Berre J.P., et al. Should pancreas imaging be recommanded in patients over 50 years when diabetes is discovered because of acute symptoms?. Diabetes Metab 30 (2004) 203-207
54. Ogawa Y., Tanaka M., Inoue K., et al. A prospective pancreatographic study of the prevalence of pancreatic carcinoma in patients with diabetes mellitus. Cancer 94 (2002) 2344-2349
55. McNulty N.J., Francis I.R., Platt J.F., et al. Multi-detector row helical CT of the pancreas: effect of contrast-enhanced multiphasic imaging on enhancement of the pancreas, peripancreatic vasculature, and pancreatic adenocarcinoma. Radiology 220 (2001) 97-102
56. Johnson C.D. Pancreatic carcinoma: Developing a protocol for multi-detector row CT. Radiology 220 (2001) 3-4
57. Tiitola M., Kivisaari L., Huuskonen M.S., et al. Computed tomography screening for lung cancer in asbestos-exposed workers. Lung Cancer 35 (2002) 17-22
58. Diederich S., Wormanns D., Semik M., et al. Screening for early lung cancer with low-dose spiral CT: Prevalence in 817 asymptomatic smokers. Radiology 222 (2002) 773-781
59. Canto M., Wroblewski L., Goggins M., et al. Screening for pancreatic neoplasia in hgh-risk individuals: The Johns Hopkins experience. Gastroenterology 122 suppl 1 (2002) A-17
60. Wiersema M.J., Vilmann P., Giovannini M., et al. Endosonography-guided fine-needle aspiration biopsy: Diagnostic accuracy and complication assessment. Gastroenterology 112 (1997) 1087-1095
61. Canto M.I., Goggins M., Yeo C.J., et al. Screening for pancreatic neoplasia in high-risk individuals: An EUS-based approach. Clin Gastroenterol Hepatol 2 (2004) 606-621
62. Rajan E., Clain J.E., Levy M.J., et al. Age-related changes in the pancreas identified by EUS: A prospective evaluation. Gastrointest Endosc 61 (2005) 401-406
63. Yusoff I.F., and Sahai A.V. A prospective, quantitative assessment of the effect of ethanol and other variables on the endosonographic appearance of the pancreas. Clin Gastroenterol Hepatol 2 (2004) 405-409